

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | postsynaptic membrane organization (GO:0001941) | 5.79664035 |
| 2 | presynaptic membrane assembly (GO:0097105) | 5.15521726 |
| 3 | behavioral response to nicotine (GO:0035095) | 4.85443135 |
| 4 | presynaptic membrane organization (GO:0097090) | 4.40543232 |
| 5 | neuronal action potential propagation (GO:0019227) | 4.32552456 |
| 6 | respiratory chain complex IV assembly (GO:0008535) | 4.25117414 |
| 7 | fucose catabolic process (GO:0019317) | 4.11439395 |
| 8 | L-fucose metabolic process (GO:0042354) | 4.11439395 |
| 9 | L-fucose catabolic process (GO:0042355) | 4.11439395 |
| 10 | facial nerve structural organization (GO:0021612) | 4.11184956 |
| 11 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.03328112 |
| 12 | cytochrome complex assembly (GO:0017004) | 4.00487631 |
| 13 | gamma-aminobutyric acid transport (GO:0015812) | 4.00265599 |
| 14 | transmission of nerve impulse (GO:0019226) | 3.92569965 |
| 15 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.82650791 |
| 16 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.79811137 |
| 17 | dendritic spine morphogenesis (GO:0060997) | 3.75699344 |
| 18 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.74873204 |
| 19 | response to pheromone (GO:0019236) | 3.71210282 |
| 20 | protein localization to synapse (GO:0035418) | 3.70563734 |
| 21 | neuron cell-cell adhesion (GO:0007158) | 3.56277789 |
| 22 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.56020527 |
| 23 | nucleobase catabolic process (GO:0046113) | 3.53215094 |
| 24 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.46546788 |
| 25 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.46248939 |
| 26 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.43790773 |
| 27 | generation of neurons (GO:0048699) | 3.42240401 |
| 28 | DNA deamination (GO:0045006) | 3.38383018 |
| 29 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.37047076 |
| 30 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.31624764 |
| 31 | proline transport (GO:0015824) | 3.31292903 |
| 32 | cranial nerve structural organization (GO:0021604) | 3.21421617 |
| 33 | glycerophospholipid catabolic process (GO:0046475) | 3.20052204 |
| 34 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.18073594 |
| 35 | synaptic transmission, cholinergic (GO:0007271) | 3.17853634 |
| 36 | vocalization behavior (GO:0071625) | 3.17223985 |
| 37 | regulation of neurotransmitter uptake (GO:0051580) | 3.15458047 |
| 38 | protein heterotetramerization (GO:0051290) | 3.14422050 |
| 39 | epithelial cilium movement (GO:0003351) | 3.11089170 |
| 40 | righting reflex (GO:0060013) | 3.10312078 |
| 41 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.10125458 |
| 42 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.07049822 |
| 43 | mannosylation (GO:0097502) | 3.06313791 |
| 44 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.03756803 |
| 45 | axon ensheathment in central nervous system (GO:0032291) | 3.02345510 |
| 46 | central nervous system myelination (GO:0022010) | 3.02345510 |
| 47 | positive regulation of membrane potential (GO:0045838) | 3.00938251 |
| 48 | regulation of pigment cell differentiation (GO:0050932) | 3.00776643 |
| 49 | cranial nerve morphogenesis (GO:0021602) | 2.97612068 |
| 50 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.94902861 |
| 51 | membrane depolarization during action potential (GO:0086010) | 2.94239616 |
| 52 | neurotransmitter secretion (GO:0007269) | 2.92142056 |
| 53 | positive regulation of dendritic spine development (GO:0060999) | 2.90311104 |
| 54 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.86930775 |
| 55 | lymphoid progenitor cell differentiation (GO:0002320) | 2.85044802 |
| 56 | protein polyglutamylation (GO:0018095) | 2.84533422 |
| 57 | mature B cell differentiation (GO:0002335) | 2.84309623 |
| 58 | superoxide anion generation (GO:0042554) | 2.83348440 |
| 59 | locomotory exploration behavior (GO:0035641) | 2.83097267 |
| 60 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.82869735 |
| 61 | axonal fasciculation (GO:0007413) | 2.81678926 |
| 62 | proteasome assembly (GO:0043248) | 2.81637466 |
| 63 | neuromuscular synaptic transmission (GO:0007274) | 2.78132754 |
| 64 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.77158914 |
| 65 | developmental pigmentation (GO:0048066) | 2.73899162 |
| 66 | auditory receptor cell stereocilium organization (GO:0060088) | 2.72443981 |
| 67 | regulation of respiratory system process (GO:0044065) | 2.69518748 |
| 68 | behavioral response to ethanol (GO:0048149) | 2.68981110 |
| 69 | mast cell activation (GO:0045576) | 2.68888420 |
| 70 | piRNA metabolic process (GO:0034587) | 2.68116669 |
| 71 | axoneme assembly (GO:0035082) | 2.67432623 |
| 72 | negative regulation of telomere maintenance (GO:0032205) | 2.67361915 |
| 73 | response to peptidoglycan (GO:0032494) | 2.67179294 |
| 74 | neuronal action potential (GO:0019228) | 2.67130153 |
| 75 | regulation of microtubule-based movement (GO:0060632) | 2.66070552 |
| 76 | synapse assembly (GO:0007416) | 2.65861531 |
| 77 | synaptic transmission, glutamatergic (GO:0035249) | 2.64833752 |
| 78 | regulation of cilium movement (GO:0003352) | 2.63290711 |
| 79 | kidney morphogenesis (GO:0060993) | 2.63095403 |
| 80 | cilium movement (GO:0003341) | 2.62283059 |
| 81 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.62203304 |
| 82 | cellular ketone body metabolic process (GO:0046950) | 2.62159155 |
| 83 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 2.61169966 |
| 84 | atrial cardiac muscle cell action potential (GO:0086014) | 2.60940780 |
| 85 | reflex (GO:0060004) | 2.60812788 |
| 86 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.59855136 |
| 87 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.59452703 |
| 88 | inner ear receptor stereocilium organization (GO:0060122) | 2.58224819 |
| 89 | regulation of synaptic vesicle transport (GO:1902803) | 2.57743108 |
| 90 | regulation of action potential (GO:0098900) | 2.57587102 |
| 91 | protein complex biogenesis (GO:0070271) | 2.56633622 |
| 92 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.56559720 |
| 93 | androgen biosynthetic process (GO:0006702) | 2.55685991 |
| 94 | negative regulation of myotube differentiation (GO:0010832) | 2.54670674 |
| 95 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.54521494 |
| 96 | detection of light stimulus involved in visual perception (GO:0050908) | 2.54521494 |
| 97 | glycosphingolipid biosynthetic process (GO:0006688) | 2.54390606 |
| 98 | cornea development in camera-type eye (GO:0061303) | 2.53604481 |
| 99 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.53519440 |
| 100 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.53255207 |
| 101 | protein localization to cilium (GO:0061512) | 2.52838868 |
| 102 | omega-hydroxylase P450 pathway (GO:0097267) | 2.52617565 |
| 103 | startle response (GO:0001964) | 2.51514609 |
| 104 | central nervous system neuron axonogenesis (GO:0021955) | 2.51081628 |
| 105 | regulation of respiratory gaseous exchange (GO:0043576) | 2.50555458 |
| 106 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.50263012 |
| 107 | glutamate receptor signaling pathway (GO:0007215) | 2.50228876 |
| 108 | multicellular organismal signaling (GO:0035637) | 2.49820020 |
| 109 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.49805476 |
| 110 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.49805476 |
| 111 | NADH dehydrogenase complex assembly (GO:0010257) | 2.49805476 |
| 112 | nonmotile primary cilium assembly (GO:0035058) | 2.49242876 |
| 113 | regulation of synapse structural plasticity (GO:0051823) | 2.48921829 |
| 114 | viral genome replication (GO:0019079) | 2.48583642 |
| 115 | regulation of neurotransmitter levels (GO:0001505) | 2.47986763 |
| 116 | regulation of female receptivity (GO:0045924) | 2.47975374 |
| 117 | indolalkylamine metabolic process (GO:0006586) | 2.47365721 |
| 118 | inositol phosphate catabolic process (GO:0071545) | 2.47289458 |
| 119 | spinal cord development (GO:0021510) | 2.47046020 |
| 120 | synaptic vesicle maturation (GO:0016188) | 2.46912742 |
| 121 | C-terminal protein lipidation (GO:0006501) | 2.46745467 |
| 122 | myeloid leukocyte mediated immunity (GO:0002444) | 2.46172889 |
| 123 | neuron recognition (GO:0008038) | 2.45687793 |
| 124 | retinal cone cell development (GO:0046549) | 2.45154148 |
| 125 | neurofilament cytoskeleton organization (GO:0060052) | 2.44443248 |
| 126 | positive regulation of synapse assembly (GO:0051965) | 2.42854141 |
| 127 | response to amphetamine (GO:0001975) | 2.41830379 |
| 128 | mature B cell differentiation involved in immune response (GO:0002313) | 2.41280751 |
| 129 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.40904797 |
| 130 | neurotransmitter transport (GO:0006836) | 2.40352355 |
| 131 | membrane invagination (GO:0010324) | 2.38954565 |
| 132 | somite development (GO:0061053) | 2.38442523 |
| 133 | exploration behavior (GO:0035640) | 2.37904928 |
| 134 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.37370460 |
| 135 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.37198607 |
| 136 | adult walking behavior (GO:0007628) | 2.35815106 |
| 137 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.35668513 |
| 138 | C-terminal protein amino acid modification (GO:0018410) | 2.35105943 |
| 139 | positive regulation of neurotransmitter transport (GO:0051590) | 2.33081653 |
| 140 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.31684695 |
| 141 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.29925149 |
| 142 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.28974015 |
| 143 | GDP-mannose metabolic process (GO:0019673) | 2.28434280 |
| 144 | dendritic cell chemotaxis (GO:0002407) | 2.27876289 |
| 145 | negative regulation of type 2 immune response (GO:0002829) | 2.27681846 |
| 146 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.27457850 |
| 147 | centriole assembly (GO:0098534) | 2.27425938 |
| 148 | mechanosensory behavior (GO:0007638) | 2.27348553 |
| 149 | long-term memory (GO:0007616) | 2.26376234 |
| 150 | neuron-neuron synaptic transmission (GO:0007270) | 2.26240429 |
| 151 | ribosomal small subunit assembly (GO:0000028) | 2.25741317 |
| 152 | cellular response to exogenous dsRNA (GO:0071360) | 2.25140749 |
| 153 | amino sugar catabolic process (GO:0046348) | 2.24602268 |
| 154 | GPI anchor biosynthetic process (GO:0006506) | 2.24036793 |
| 155 | synaptic vesicle exocytosis (GO:0016079) | 2.23937882 |
| 156 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.23277790 |
| 157 | regulation of synapse assembly (GO:0051963) | 2.22402059 |
| 158 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.21936682 |
| 159 | mast cell degranulation (GO:0043303) | 2.21885431 |
| 160 | mast cell activation involved in immune response (GO:0002279) | 2.21885431 |
| 161 | defense response to protozoan (GO:0042832) | 2.21230832 |
| 162 | sympathetic nervous system development (GO:0048485) | 2.19333375 |
| 163 | nucleoside diphosphate catabolic process (GO:0009134) | 2.18158711 |
| 164 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.16722511 |
| 165 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.16452758 |
| 166 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.15638994 |
| 167 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.15638994 |
| 168 | mesonephros development (GO:0001823) | 2.13223787 |
| 169 | auditory behavior (GO:0031223) | 2.12195185 |
| 170 | mitochondrion degradation (GO:0000422) | 2.11652356 |
| 171 | polyketide metabolic process (GO:0030638) | 2.11139892 |
| 172 | doxorubicin metabolic process (GO:0044598) | 2.11139892 |
| 173 | daunorubicin metabolic process (GO:0044597) | 2.11139892 |
| 174 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.11128563 |
| 175 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.10953654 |
| 176 | negative regulation of viral genome replication (GO:0045071) | 2.10216399 |
| 177 | response to interferon-beta (GO:0035456) | 2.10017120 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 7.86482206 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.46644609 |
| 3 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.33554825 |
| 4 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.24166992 |
| 5 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.81153528 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.75546378 |
| 7 | VDR_22108803_ChIP-Seq_LS180_Human | 2.70010266 |
| 8 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.42252389 |
| 9 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.30334024 |
| 10 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.25647796 |
| 11 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.23171989 |
| 12 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.20777990 |
| 13 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.18095682 |
| 14 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.12960621 |
| 15 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.08919777 |
| 16 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.06783651 |
| 17 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.02840872 |
| 18 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.00454786 |
| 19 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.91878206 |
| 20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.91600932 |
| 21 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.90471751 |
| 22 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.86333410 |
| 23 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.86305102 |
| 24 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.86305102 |
| 25 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.85966242 |
| 26 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.85597729 |
| 27 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.78000444 |
| 28 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.77350383 |
| 29 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.70977021 |
| 30 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70968138 |
| 31 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.69068289 |
| 32 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.68625739 |
| 33 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.68244933 |
| 34 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.67975889 |
| 35 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.66121652 |
| 36 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.65380456 |
| 37 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.61993219 |
| 38 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.61478060 |
| 39 | FUS_26573619_Chip-Seq_HEK293_Human | 1.61253860 |
| 40 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.58596125 |
| 41 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.57870058 |
| 42 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.54320905 |
| 43 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.53898977 |
| 44 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.53182620 |
| 45 | EWS_26573619_Chip-Seq_HEK293_Human | 1.51991492 |
| 46 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.51803263 |
| 47 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.49120768 |
| 48 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.48156095 |
| 49 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.47595389 |
| 50 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.46118443 |
| 51 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.44565720 |
| 52 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.43202640 |
| 53 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.42702884 |
| 54 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.41927020 |
| 55 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.41670141 |
| 56 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.41184462 |
| 57 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.40743298 |
| 58 | STAT3_23295773_ChIP-Seq_U87_Human | 1.40054859 |
| 59 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.39557473 |
| 60 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.38295835 |
| 61 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.38290139 |
| 62 | TCF4_23295773_ChIP-Seq_U87_Human | 1.37930639 |
| 63 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.37393685 |
| 64 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.37289601 |
| 65 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.36997294 |
| 66 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.35564985 |
| 67 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.35157502 |
| 68 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.34875186 |
| 69 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.34790570 |
| 70 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.34788211 |
| 71 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.34732516 |
| 72 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.34671983 |
| 73 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.33100904 |
| 74 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.32061144 |
| 75 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.30989514 |
| 76 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.30989514 |
| 77 | P300_19829295_ChIP-Seq_ESCs_Human | 1.30405461 |
| 78 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.28961145 |
| 79 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.28950496 |
| 80 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.28832017 |
| 81 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.28830102 |
| 82 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.28751440 |
| 83 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.27350976 |
| 84 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.26739920 |
| 85 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.25830696 |
| 86 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.24633101 |
| 87 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.22577169 |
| 88 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.22063587 |
| 89 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20702933 |
| 90 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.19983739 |
| 91 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.19634636 |
| 92 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.19197607 |
| 93 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.19160692 |
| 94 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.19160692 |
| 95 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.18527037 |
| 96 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.18186499 |
| 97 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.17957408 |
| 98 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.16948312 |
| 99 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.16938271 |
| 100 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.16924034 |
| 101 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.16553026 |
| 102 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.16383283 |
| 103 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.16346202 |
| 104 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.16313663 |
| 105 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.15696754 |
| 106 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.15473645 |
| 107 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.14920328 |
| 108 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.14649031 |
| 109 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.14312876 |
| 110 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.14312876 |
| 111 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.13872296 |
| 112 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.13369876 |
| 113 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.12832971 |
| 114 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.11724846 |
| 115 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.11621000 |
| 116 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.11495865 |
| 117 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.11495865 |
| 118 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.11034869 |
| 119 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.10181194 |
| 120 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.09503240 |
| 121 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.08347416 |
| 122 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07318646 |
| 123 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.07122207 |
| 124 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.05558412 |
| 125 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.05411162 |
| 126 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.03787552 |
| 127 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.03099523 |
| 128 | NCOR_22424771_ChIP-Seq_293T_Human | 1.02916199 |
| 129 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.01898975 |
| 130 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99356663 |
| 131 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.99129129 |
| 132 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.99063623 |
| 133 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.97047923 |
| 134 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.96842600 |
| 135 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.96735497 |
| 136 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.95089029 |
| 137 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.94864870 |
| 138 | AR_25329375_ChIP-Seq_VCAP_Human | 0.94728907 |
| 139 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94652927 |
| 140 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.94625070 |
| 141 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.94025105 |
| 142 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92122865 |
| 143 | KDM2B_26808549_Chip-Seq_REH_Human | 0.90209770 |
| 144 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.89370039 |
| 145 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.89363207 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.29888132 |
| 2 | MP0001188_hyperpigmentation | 3.76161775 |
| 3 | MP0006292_abnormal_olfactory_placode | 3.44823215 |
| 4 | MP0009379_abnormal_foot_pigmentation | 3.24725800 |
| 5 | MP0005409_darkened_coat_color | 3.10964186 |
| 6 | MP0000015_abnormal_ear_pigmentation | 2.94874046 |
| 7 | MP0005174_abnormal_tail_pigmentation | 2.88172327 |
| 8 | MP0003136_yellow_coat_color | 2.68619759 |
| 9 | MP0004859_abnormal_synaptic_plasticity | 2.65719166 |
| 10 | MP0002876_abnormal_thyroid_physiology | 2.38613217 |
| 11 | MP0004885_abnormal_endolymph | 2.33582828 |
| 12 | MP0001986_abnormal_taste_sensitivity | 2.24628915 |
| 13 | MP0008877_abnormal_DNA_methylation | 2.12671727 |
| 14 | MP0005423_abnormal_somatic_nervous | 2.09707062 |
| 15 | MP0001968_abnormal_touch/_nociception | 2.06671563 |
| 16 | MP0003635_abnormal_synaptic_transmissio | 2.02865118 |
| 17 | MP0009745_abnormal_behavioral_response | 1.99788287 |
| 18 | MP0006276_abnormal_autonomic_nervous | 1.97969383 |
| 19 | MP0000372_irregular_coat_pigmentation | 1.93508389 |
| 20 | MP0002638_abnormal_pupillary_reflex | 1.89335700 |
| 21 | MP0003724_increased_susceptibility_to | 1.83760485 |
| 22 | MP0006072_abnormal_retinal_apoptosis | 1.83757597 |
| 23 | MP0005075_abnormal_melanosome_morpholog | 1.82222209 |
| 24 | MP0002909_abnormal_adrenal_gland | 1.77787487 |
| 25 | MP0004381_abnormal_hair_follicle | 1.76905230 |
| 26 | MP0001835_abnormal_antigen_presentation | 1.75040293 |
| 27 | MP0008260_abnormal_autophagy | 1.72621778 |
| 28 | MP0005645_abnormal_hypothalamus_physiol | 1.70805774 |
| 29 | MP0005253_abnormal_eye_physiology | 1.68394427 |
| 30 | MP0002095_abnormal_skin_pigmentation | 1.67758108 |
| 31 | MP0002148_abnormal_hypersensitivity_rea | 1.67450973 |
| 32 | MP0009046_muscle_twitch | 1.65417520 |
| 33 | MP0002735_abnormal_chemical_nociception | 1.64297150 |
| 34 | MP0002272_abnormal_nervous_system | 1.63715707 |
| 35 | MP0009785_altered_susceptibility_to | 1.62269607 |
| 36 | MP0002822_catalepsy | 1.60747044 |
| 37 | MP0005671_abnormal_response_to | 1.60535122 |
| 38 | MP0008872_abnormal_physiological_respon | 1.59598079 |
| 39 | MP0002064_seizures | 1.58732202 |
| 40 | MP0005646_abnormal_pituitary_gland | 1.57891551 |
| 41 | MP0002734_abnormal_mechanical_nocicepti | 1.56741557 |
| 42 | MP0001486_abnormal_startle_reflex | 1.56612054 |
| 43 | MP0000681_abnormal_thyroid_gland | 1.56567236 |
| 44 | MP0004133_heterotaxia | 1.49313439 |
| 45 | MP0001529_abnormal_vocalization | 1.49190181 |
| 46 | MP0002653_abnormal_ependyma_morphology | 1.47713782 |
| 47 | MP0003011_delayed_dark_adaptation | 1.47068866 |
| 48 | MP0003195_calcinosis | 1.46675923 |
| 49 | MP0002837_dystrophic_cardiac_calcinosis | 1.46070510 |
| 50 | MP0002067_abnormal_sensory_capabilities | 1.44619085 |
| 51 | MP0005171_absent_coat_pigmentation | 1.44327968 |
| 52 | MP0002736_abnormal_nociception_after | 1.43283617 |
| 53 | MP0003879_abnormal_hair_cell | 1.43034670 |
| 54 | MP0004270_analgesia | 1.42958906 |
| 55 | MP0008569_lethality_at_weaning | 1.42023942 |
| 56 | MP0002572_abnormal_emotion/affect_behav | 1.39887878 |
| 57 | MP0002063_abnormal_learning/memory/cond | 1.39462915 |
| 58 | MP0004142_abnormal_muscle_tone | 1.39096500 |
| 59 | MP0003646_muscle_fatigue | 1.37799360 |
| 60 | MP0000955_abnormal_spinal_cord | 1.37434982 |
| 61 | MP0002557_abnormal_social/conspecific_i | 1.36244695 |
| 62 | MP0001970_abnormal_pain_threshold | 1.35173106 |
| 63 | MP0001502_abnormal_circadian_rhythm | 1.33927552 |
| 64 | MP0003122_maternal_imprinting | 1.33814865 |
| 65 | MP0001485_abnormal_pinna_reflex | 1.33759496 |
| 66 | MP0003283_abnormal_digestive_organ | 1.33087819 |
| 67 | MP0001501_abnormal_sleep_pattern | 1.26477182 |
| 68 | MP0010386_abnormal_urinary_bladder | 1.25589642 |
| 69 | MP0002751_abnormal_autonomic_nervous | 1.25222942 |
| 70 | MP0001984_abnormal_olfaction | 1.23808696 |
| 71 | MP0002928_abnormal_bile_duct | 1.23614812 |
| 72 | MP0001905_abnormal_dopamine_level | 1.20829121 |
| 73 | MP0004043_abnormal_pH_regulation | 1.17312935 |
| 74 | MP0003787_abnormal_imprinting | 1.16727875 |
| 75 | MP0005000_abnormal_immune_tolerance | 1.13505581 |
| 76 | MP0000631_abnormal_neuroendocrine_gland | 1.12045144 |
| 77 | MP0002184_abnormal_innervation | 1.11584959 |
| 78 | MP0005025_abnormal_response_to | 1.10972421 |
| 79 | MP0002733_abnormal_thermal_nociception | 1.10319773 |
| 80 | MP0002752_abnormal_somatic_nervous | 1.09811289 |
| 81 | MP0009780_abnormal_chondrocyte_physiolo | 1.09719972 |
| 82 | MP0005167_abnormal_blood-brain_barrier | 1.08926918 |
| 83 | MP0000566_synostosis | 1.08231456 |
| 84 | MP0002229_neurodegeneration | 1.07309888 |
| 85 | MP0000427_abnormal_hair_cycle | 1.06803624 |
| 86 | MP0002277_abnormal_respiratory_mucosa | 1.05305520 |
| 87 | MP0002102_abnormal_ear_morphology | 1.04750238 |
| 88 | MP0003121_genomic_imprinting | 1.03588147 |
| 89 | MP0003763_abnormal_thymus_physiology | 1.02317044 |
| 90 | MP0005499_abnormal_olfactory_system | 1.01292770 |
| 91 | MP0005394_taste/olfaction_phenotype | 1.01292770 |
| 92 | MP0002419_abnormal_innate_immunity | 1.00115037 |
| 93 | MP0002177_abnormal_outer_ear | 0.99667265 |
| 94 | MP0008995_early_reproductive_senescence | 0.98449698 |
| 95 | MP0003633_abnormal_nervous_system | 0.96630276 |
| 96 | MP0004147_increased_porphyrin_level | 0.96431698 |
| 97 | MP0004145_abnormal_muscle_electrophysio | 0.96052346 |
| 98 | MP0002066_abnormal_motor_capabilities/c | 0.93864951 |
| 99 | MP0003119_abnormal_digestive_system | 0.91416154 |
| 100 | MP0001944_abnormal_pancreas_morphology | 0.91005851 |
| 101 | MP0001963_abnormal_hearing_physiology | 0.90047915 |
| 102 | MP0002009_preneoplasia | 0.90000010 |
| 103 | MP0000026_abnormal_inner_ear | 0.88464211 |
| 104 | MP0008875_abnormal_xenobiotic_pharmacok | 0.88052369 |
| 105 | MP0008789_abnormal_olfactory_epithelium | 0.87615640 |
| 106 | MP0003436_decreased_susceptibility_to | 0.87246373 |
| 107 | MP0001819_abnormal_immune_cell | 0.86849537 |
| 108 | MP0005195_abnormal_posterior_eye | 0.86743048 |
| 109 | MP0002420_abnormal_adaptive_immunity | 0.86707285 |
| 110 | MP0002723_abnormal_immune_serum | 0.86542596 |
| 111 | MP0003938_abnormal_ear_development | 0.86312277 |
| 112 | MP0000049_abnormal_middle_ear | 0.84769702 |
| 113 | MP0002152_abnormal_brain_morphology | 0.83324663 |
| 114 | MP0003137_abnormal_impulse_conducting | 0.83030537 |
| 115 | MP0005187_abnormal_penis_morphology | 0.81810066 |
| 116 | MP0005084_abnormal_gallbladder_morpholo | 0.78739000 |
| 117 | MP0002160_abnormal_reproductive_system | 0.78618806 |
| 118 | MP0000678_abnormal_parathyroid_gland | 0.77805068 |
| 119 | MP0000230_abnormal_systemic_arterial | 0.76674684 |
| 120 | MP0002452_abnormal_antigen_presenting | 0.76586277 |
| 121 | MP0000778_abnormal_nervous_system | 0.76452910 |
| 122 | MP0002163_abnormal_gland_morphology | 0.76260113 |
| 123 | MP0002693_abnormal_pancreas_physiology | 0.75844695 |
| 124 | MP0003315_abnormal_perineum_morphology | 0.73872574 |
| 125 | MP0004742_abnormal_vestibular_system | 0.73364629 |
| 126 | MP0008058_abnormal_DNA_repair | 0.73059296 |
| 127 | MP0005551_abnormal_eye_electrophysiolog | 0.72862389 |
| 128 | MP0002938_white_spotting | 0.71946632 |
| 129 | MP0005379_endocrine/exocrine_gland_phen | 0.71888998 |
| 130 | MP0001664_abnormal_digestion | 0.71580000 |
| 131 | MP0001800_abnormal_humoral_immune | 0.71202476 |
| 132 | MP0002882_abnormal_neuron_morphology | 0.68471912 |
| 133 | MP0000569_abnormal_digit_pigmentation | 0.68073441 |
| 134 | MP0001919_abnormal_reproductive_system | 0.66033793 |
| 135 | MP0004811_abnormal_neuron_physiology | 0.65759331 |
| 136 | MP0005386_behavior/neurological_phenoty | 0.65648764 |
| 137 | MP0004924_abnormal_behavior | 0.65648764 |
| 138 | MP0001440_abnormal_grooming_behavior | 0.65539461 |
| 139 | MP0001186_pigmentation_phenotype | 0.64926254 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Type I transferrin isoform profile (HP:0003642) | 5.73965137 |
| 2 | Reduced antithrombin III activity (HP:0001976) | 5.66019186 |
| 3 | Focal motor seizures (HP:0011153) | 4.30668957 |
| 4 | Type II lissencephaly (HP:0007260) | 3.91354718 |
| 5 | Abnormal protein glycosylation (HP:0012346) | 3.87605556 |
| 6 | Abnormal glycosylation (HP:0012345) | 3.87605556 |
| 7 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.87605556 |
| 8 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.87605556 |
| 9 | Hypothermia (HP:0002045) | 3.84547566 |
| 10 | Nonprogressive disorder (HP:0003680) | 3.52379294 |
| 11 | Abnormality of midbrain morphology (HP:0002418) | 3.49564350 |
| 12 | Molar tooth sign on MRI (HP:0002419) | 3.49564350 |
| 13 | Nephronophthisis (HP:0000090) | 3.43398132 |
| 14 | Febrile seizures (HP:0002373) | 3.28099802 |
| 15 | Thyroid-stimulating hormone excess (HP:0002925) | 3.27971415 |
| 16 | Congenital stationary night blindness (HP:0007642) | 3.19120330 |
| 17 | Hemiparesis (HP:0001269) | 3.10163451 |
| 18 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.09836272 |
| 19 | Focal seizures (HP:0007359) | 2.90961013 |
| 20 | Abnormal drinking behavior (HP:0030082) | 2.88897829 |
| 21 | Polydipsia (HP:0001959) | 2.88897829 |
| 22 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.87540792 |
| 23 | Retinal dysplasia (HP:0007973) | 2.81775139 |
| 24 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.80899514 |
| 25 | Hyperventilation (HP:0002883) | 2.80493572 |
| 26 | Lissencephaly (HP:0001339) | 2.76550776 |
| 27 | Abnormality of the renal medulla (HP:0100957) | 2.75664362 |
| 28 | Medial flaring of the eyebrow (HP:0010747) | 2.72983523 |
| 29 | Chronic obstructive pulmonary disease (HP:0006510) | 2.70316048 |
| 30 | Obstructive lung disease (HP:0006536) | 2.70316048 |
| 31 | Renal Fanconi syndrome (HP:0001994) | 2.70256757 |
| 32 | Cerebellar dysplasia (HP:0007033) | 2.68026298 |
| 33 | Severe visual impairment (HP:0001141) | 2.63400022 |
| 34 | True hermaphroditism (HP:0010459) | 2.59762409 |
| 35 | Increased hepatocellular lipid droplets (HP:0006565) | 2.57576131 |
| 36 | Stomatitis (HP:0010280) | 2.57016316 |
| 37 | Abnormality of magnesium homeostasis (HP:0004921) | 2.54619128 |
| 38 | Gaze-evoked nystagmus (HP:0000640) | 2.53639091 |
| 39 | Abolished electroretinogram (ERG) (HP:0000550) | 2.50870820 |
| 40 | Pachygyria (HP:0001302) | 2.50392444 |
| 41 | Inability to walk (HP:0002540) | 2.48024366 |
| 42 | Dry hair (HP:0011359) | 2.47295340 |
| 43 | Large for gestational age (HP:0001520) | 2.46113672 |
| 44 | Myokymia (HP:0002411) | 2.45796294 |
| 45 | Type 2 muscle fiber atrophy (HP:0003554) | 2.45706784 |
| 46 | Abnormality of the renal cortex (HP:0011035) | 2.41863315 |
| 47 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.36911289 |
| 48 | Progressive cerebellar ataxia (HP:0002073) | 2.36565193 |
| 49 | Tubular atrophy (HP:0000092) | 2.36387966 |
| 50 | Gait imbalance (HP:0002141) | 2.35657024 |
| 51 | Mediastinal lymphadenopathy (HP:0100721) | 2.34882414 |
| 52 | 3-Methylglutaconic aciduria (HP:0003535) | 2.34239716 |
| 53 | Recurrent abscess formation (HP:0002722) | 2.33981431 |
| 54 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.33165872 |
| 55 | Meningitis (HP:0001287) | 2.31574588 |
| 56 | Cystic liver disease (HP:0006706) | 2.31283343 |
| 57 | Chronic hepatic failure (HP:0100626) | 2.29031000 |
| 58 | Exertional dyspnea (HP:0002875) | 2.27519938 |
| 59 | Abnormality of the prostate (HP:0008775) | 2.25665290 |
| 60 | Aplastic anemia (HP:0001915) | 2.24518629 |
| 61 | Cortical visual impairment (HP:0100704) | 2.24434312 |
| 62 | Atonic seizures (HP:0010819) | 2.24230270 |
| 63 | Ocular albinism (HP:0001107) | 2.24020618 |
| 64 | Polyphagia (HP:0002591) | 2.23282403 |
| 65 | Severe muscular hypotonia (HP:0006829) | 2.22417851 |
| 66 | Absent speech (HP:0001344) | 2.20543033 |
| 67 | Pendular nystagmus (HP:0012043) | 2.20137071 |
| 68 | Dialeptic seizures (HP:0011146) | 2.19765165 |
| 69 | Iris hypopigmentation (HP:0007730) | 2.19231742 |
| 70 | Retrobulbar optic neuritis (HP:0100654) | 2.18908530 |
| 71 | Optic neuritis (HP:0100653) | 2.18908530 |
| 72 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.17445765 |
| 73 | Progressive macrocephaly (HP:0004481) | 2.15720789 |
| 74 | Attenuation of retinal blood vessels (HP:0007843) | 2.15254700 |
| 75 | Polyuria (HP:0000103) | 2.15220672 |
| 76 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.14707298 |
| 77 | Hypoplasia of the fovea (HP:0007750) | 2.14707298 |
| 78 | Myositis (HP:0100614) | 2.14686435 |
| 79 | Abnormality of secondary sexual hair (HP:0009888) | 2.14462220 |
| 80 | Abnormality of the axillary hair (HP:0100134) | 2.14462220 |
| 81 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.13756658 |
| 82 | Muscle fiber atrophy (HP:0100295) | 2.11340149 |
| 83 | Hepatocellular necrosis (HP:0001404) | 2.08748897 |
| 84 | Decreased circulating renin level (HP:0003351) | 2.08428375 |
| 85 | Genetic anticipation (HP:0003743) | 2.07646102 |
| 86 | Stomach cancer (HP:0012126) | 2.07549459 |
| 87 | Abnormality of the labia minora (HP:0012880) | 2.07334111 |
| 88 | Increased corneal curvature (HP:0100692) | 2.06740858 |
| 89 | Keratoconus (HP:0000563) | 2.06740858 |
| 90 | Abnormal number of erythroid precursors (HP:0012131) | 2.06593825 |
| 91 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.05360078 |
| 92 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.05360078 |
| 93 | Asplenia (HP:0001746) | 2.04454878 |
| 94 | Absent/shortened dynein arms (HP:0200106) | 2.04337797 |
| 95 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.04337797 |
| 96 | Split foot (HP:0001839) | 2.03830704 |
| 97 | Optic nerve hypoplasia (HP:0000609) | 2.03717829 |
| 98 | Thoracic kyphosis (HP:0002942) | 2.03115482 |
| 99 | Abnormality of the pons (HP:0007361) | 2.02238250 |
| 100 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.99834593 |
| 101 | Epileptic encephalopathy (HP:0200134) | 1.99104351 |
| 102 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.98632943 |
| 103 | Hypoplasia of the pons (HP:0012110) | 1.98172281 |
| 104 | Oligodactyly (hands) (HP:0001180) | 1.98065989 |
| 105 | Acute necrotizing encephalopathy (HP:0006965) | 1.97626908 |
| 106 | Intestinal atresia (HP:0011100) | 1.96047827 |
| 107 | Decreased central vision (HP:0007663) | 1.95977999 |
| 108 | Abnormal sex determination (HP:0012244) | 1.95917646 |
| 109 | Sex reversal (HP:0012245) | 1.95917646 |
| 110 | Hypsarrhythmia (HP:0002521) | 1.95180765 |
| 111 | Concave nail (HP:0001598) | 1.93973024 |
| 112 | Congenital primary aphakia (HP:0007707) | 1.93662217 |
| 113 | Recurrent cutaneous fungal infections (HP:0011370) | 1.93655289 |
| 114 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.93655289 |
| 115 | Sclerocornea (HP:0000647) | 1.93228353 |
| 116 | Supernumerary spleens (HP:0009799) | 1.92030750 |
| 117 | Pancreatic fibrosis (HP:0100732) | 1.91994972 |
| 118 | Epileptiform EEG discharges (HP:0011182) | 1.90586150 |
| 119 | EEG with generalized epileptiform discharges (HP:0011198) | 1.90431887 |
| 120 | Generalized tonic-clonic seizures (HP:0002069) | 1.89833477 |
| 121 | Lipid accumulation in hepatocytes (HP:0006561) | 1.89750983 |
| 122 | Increased IgM level (HP:0003496) | 1.88724060 |
| 123 | Clubbing of toes (HP:0100760) | 1.87904980 |
| 124 | Abnormality of renal resorption (HP:0011038) | 1.87624013 |
| 125 | Congenital sensorineural hearing impairment (HP:0008527) | 1.87303246 |
| 126 | Generalized hypopigmentation of hair (HP:0011358) | 1.87059422 |
| 127 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.86553343 |
| 128 | Absence seizures (HP:0002121) | 1.86504958 |
| 129 | Optic disc pallor (HP:0000543) | 1.86094427 |
| 130 | Genital tract atresia (HP:0001827) | 1.85721871 |
| 131 | Spinal canal stenosis (HP:0003416) | 1.82771448 |
| 132 | Nephrogenic diabetes insipidus (HP:0009806) | 1.81670969 |
| 133 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.81665187 |
| 134 | Mitochondrial inheritance (HP:0001427) | 1.81513828 |
| 135 | Recurrent bacterial skin infections (HP:0005406) | 1.81150660 |
| 136 | Furrowed tongue (HP:0000221) | 1.80557920 |
| 137 | Anencephaly (HP:0002323) | 1.79710479 |
| 138 | Progressive inability to walk (HP:0002505) | 1.79460815 |
| 139 | Patchy hypopigmentation of hair (HP:0011365) | 1.78949014 |
| 140 | Eczematoid dermatitis (HP:0000976) | 1.78925692 |
| 141 | Vaginal atresia (HP:0000148) | 1.78472236 |
| 142 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.78317966 |
| 143 | Horizontal nystagmus (HP:0000666) | 1.77862608 |
| 144 | Ketoacidosis (HP:0001993) | 1.77210943 |
| 145 | Abnormality of the fovea (HP:0000493) | 1.76336227 |
| 146 | Neoplasm of the adrenal cortex (HP:0100641) | 1.75779162 |
| 147 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.75422446 |
| 148 | Agitation (HP:0000713) | 1.73794126 |
| 149 | Hypomagnesemia (HP:0002917) | 1.73530081 |
| 150 | Abnormal urine output (HP:0012590) | 1.73345823 |
| 151 | Chromsome breakage (HP:0040012) | 1.73266888 |
| 152 | Abnormality of the preputium (HP:0100587) | 1.73255435 |
| 153 | Bile duct proliferation (HP:0001408) | 1.72148596 |
| 154 | Abnormal biliary tract physiology (HP:0012439) | 1.72148596 |
| 155 | Congenital hepatic fibrosis (HP:0002612) | 1.71684760 |
| 156 | Increased intramyocellular lipid droplets (HP:0012240) | 1.71276034 |
| 157 | Abnormal eating behavior (HP:0100738) | 1.71195077 |
| 158 | Pancreatic cysts (HP:0001737) | 1.71054080 |
| 159 | Status epilepticus (HP:0002133) | 1.70741513 |
| 160 | Methylmalonic acidemia (HP:0002912) | 1.70658683 |
| 161 | Pulmonary fibrosis (HP:0002206) | 1.70536566 |
| 162 | Abnormality of dental color (HP:0011073) | 1.70452135 |
| 163 | Drooling (HP:0002307) | 1.70227597 |
| 164 | Obstructive sleep apnea (HP:0002870) | 1.70204503 |
| 165 | Amelogenesis imperfecta (HP:0000705) | 1.69881300 |
| 166 | Broad-based gait (HP:0002136) | 1.68478787 |
| 167 | Bradycardia (HP:0001662) | 1.67122344 |
| 168 | Orchitis (HP:0100796) | 1.67119635 |
| 169 | Agammaglobulinemia (HP:0004432) | 1.66898210 |
| 170 | Limb dystonia (HP:0002451) | 1.64894656 |
| 171 | Hemoptysis (HP:0002105) | 1.64264667 |
| 172 | Annular pancreas (HP:0001734) | 1.64028549 |
| 173 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.63300705 |
| 174 | Fair hair (HP:0002286) | 1.62655712 |
| 175 | Basal ganglia calcification (HP:0002135) | 1.62378451 |
| 176 | Sleep apnea (HP:0010535) | 1.61563785 |
| 177 | Median cleft lip (HP:0000161) | 1.61272280 |
| 178 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.60719493 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TNIK | 5.95109003 |
| 2 | FRK | 4.81388292 |
| 3 | CASK | 3.69965242 |
| 4 | MUSK | 3.46589649 |
| 5 | EIF2AK3 | 3.30723031 |
| 6 | MAP2K7 | 3.00935907 |
| 7 | MKNK2 | 2.75619604 |
| 8 | STK16 | 2.65169395 |
| 9 | MAP4K2 | 2.59271498 |
| 10 | IRAK4 | 2.44629304 |
| 11 | MAP3K12 | 2.32081433 |
| 12 | WNK3 | 2.29618215 |
| 13 | NTRK3 | 2.19126176 |
| 14 | IRAK3 | 2.17931905 |
| 15 | FGFR2 | 2.13861768 |
| 16 | NLK | 2.10397269 |
| 17 | CAMKK2 | 2.01470178 |
| 18 | INSRR | 1.91986373 |
| 19 | PHKG1 | 1.90552981 |
| 20 | PHKG2 | 1.90552981 |
| 21 | PRPF4B | 1.87568157 |
| 22 | DYRK2 | 1.86200220 |
| 23 | FES | 1.85725790 |
| 24 | NME2 | 1.84877101 |
| 25 | WNK4 | 1.74633126 |
| 26 | TXK | 1.66219185 |
| 27 | RIPK4 | 1.61787062 |
| 28 | OXSR1 | 1.61535987 |
| 29 | MAPK13 | 1.56829927 |
| 30 | EIF2AK2 | 1.54936198 |
| 31 | NUAK1 | 1.53840518 |
| 32 | MKNK1 | 1.51961623 |
| 33 | CDK19 | 1.51642590 |
| 34 | PAK3 | 1.50125972 |
| 35 | TEC | 1.49594069 |
| 36 | BMPR2 | 1.47198062 |
| 37 | STK38 | 1.46389420 |
| 38 | CLK1 | 1.40752931 |
| 39 | SRPK1 | 1.35286386 |
| 40 | STK39 | 1.35267934 |
| 41 | SIK2 | 1.34163216 |
| 42 | TRIM28 | 1.34138928 |
| 43 | YES1 | 1.27774304 |
| 44 | IRAK2 | 1.27283693 |
| 45 | TLK1 | 1.26434289 |
| 46 | PRKD2 | 1.21910251 |
| 47 | ADRBK2 | 1.21116408 |
| 48 | MAP3K14 | 1.18123025 |
| 49 | MARK1 | 1.15802701 |
| 50 | CAMK1 | 1.15018104 |
| 51 | CSNK1G2 | 1.13853477 |
| 52 | PNCK | 1.09356741 |
| 53 | CAMKK1 | 1.04261372 |
| 54 | PLK2 | 1.03837219 |
| 55 | VRK1 | 1.00652739 |
| 56 | IRAK1 | 0.99420736 |
| 57 | PINK1 | 0.99340910 |
| 58 | TNK2 | 0.97537990 |
| 59 | PRKD3 | 0.95726514 |
| 60 | ZAK | 0.95156873 |
| 61 | STK11 | 0.92364508 |
| 62 | CDK3 | 0.91642175 |
| 63 | CSNK1G3 | 0.90691002 |
| 64 | MINK1 | 0.90197077 |
| 65 | KIT | 0.89846856 |
| 66 | NEK6 | 0.88143829 |
| 67 | ADRBK1 | 0.88007797 |
| 68 | GRK7 | 0.85904082 |
| 69 | IKBKE | 0.84573248 |
| 70 | BLK | 0.84134508 |
| 71 | SGK494 | 0.83149092 |
| 72 | SGK223 | 0.83149092 |
| 73 | UHMK1 | 0.83039969 |
| 74 | TAOK2 | 0.82019422 |
| 75 | PRKCI | 0.80485214 |
| 76 | BCR | 0.80480817 |
| 77 | TAOK3 | 0.78577058 |
| 78 | PAK6 | 0.77690341 |
| 79 | PRKCH | 0.77130413 |
| 80 | ACVR1B | 0.77084194 |
| 81 | PIM2 | 0.77024720 |
| 82 | EPHA4 | 0.76827451 |
| 83 | CSNK1A1L | 0.75006717 |
| 84 | BTK | 0.73722445 |
| 85 | SIK3 | 0.72895091 |
| 86 | IKBKB | 0.71283309 |
| 87 | SYK | 0.71197647 |
| 88 | PKN1 | 0.69893352 |
| 89 | BMPR1B | 0.66834813 |
| 90 | ITK | 0.64401072 |
| 91 | MAP2K6 | 0.64168576 |
| 92 | PTK2B | 0.63024336 |
| 93 | PRKG2 | 0.62815423 |
| 94 | EPHA3 | 0.62315849 |
| 95 | GRK5 | 0.61532016 |
| 96 | CSNK1A1 | 0.60826881 |
| 97 | LYN | 0.57147891 |
| 98 | DAPK1 | 0.54827563 |
| 99 | STK38L | 0.53470087 |
| 100 | ERBB3 | 0.52025207 |
| 101 | NTRK2 | 0.51747703 |
| 102 | HIPK2 | 0.51597778 |
| 103 | MAP3K9 | 0.50810949 |
| 104 | CAMK2B | 0.50456756 |
| 105 | CAMK2A | 0.50406464 |
| 106 | MAP3K1 | 0.48587132 |
| 107 | SGK2 | 0.47691765 |
| 108 | PRKCZ | 0.47528862 |
| 109 | ERBB2 | 0.47350945 |
| 110 | MAPKAPK5 | 0.45500669 |
| 111 | MAP3K4 | 0.44391407 |
| 112 | BCKDK | 0.43597827 |
| 113 | PRKCG | 0.42446070 |
| 114 | MAP3K13 | 0.42062979 |
| 115 | PRKCQ | 0.42029453 |
| 116 | SGK1 | 0.42025171 |
| 117 | PRKAA1 | 0.41369390 |
| 118 | CDK8 | 0.41138572 |
| 119 | CCNB1 | 0.40727065 |
| 120 | CDK5 | 0.39474225 |
| 121 | DAPK2 | 0.39139227 |
| 122 | CAMK4 | 0.38933571 |
| 123 | DYRK1A | 0.38267664 |
| 124 | PLK3 | 0.37314436 |
| 125 | FER | 0.36772434 |
| 126 | CSNK1D | 0.36284504 |
| 127 | MARK3 | 0.35949002 |
| 128 | ARAF | 0.34469258 |
| 129 | TIE1 | 0.33717343 |
| 130 | PRKCA | 0.33316011 |
| 131 | TYRO3 | 0.32850335 |
| 132 | PLK4 | 0.32285264 |
| 133 | MAPK15 | 0.31490385 |
| 134 | MATK | 0.31395566 |
| 135 | MAP3K11 | 0.31052996 |
| 136 | MAPK4 | 0.30384435 |
| 137 | PRKCE | 0.30197699 |
| 138 | TBK1 | 0.29676147 |
| 139 | PIK3CA | 0.29606455 |
| 140 | PRKCD | 0.28631115 |
| 141 | HCK | 0.26744762 |
| 142 | NME1 | 0.26385021 |
| 143 | GRK1 | 0.25619643 |
| 144 | CSNK1G1 | 0.24640966 |
| 145 | CAMK2D | 0.22726762 |
| 146 | LCK | 0.22497620 |
| 147 | PRKACA | 0.21051067 |
| 148 | MAP2K4 | 0.20624999 |
| 149 | MAP3K6 | 0.20594310 |
| 150 | BRAF | 0.20592361 |
| 151 | PRKG1 | 0.19711464 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 2.88891626 |
| 2 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.68048448 |
| 3 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.21897001 |
| 4 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.14192195 |
| 5 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.11788614 |
| 6 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.06370869 |
| 7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.98666758 |
| 8 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.96284153 |
| 9 | Ribosome_Homo sapiens_hsa03010 | 1.91417512 |
| 10 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.87401661 |
| 11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.82561241 |
| 12 | Protein export_Homo sapiens_hsa03060 | 1.81475877 |
| 13 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.81373766 |
| 14 | Morphine addiction_Homo sapiens_hsa05032 | 1.77641757 |
| 15 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.73636804 |
| 16 | DNA replication_Homo sapiens_hsa03030 | 1.70622377 |
| 17 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.70505444 |
| 18 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.69142713 |
| 19 | Olfactory transduction_Homo sapiens_hsa04740 | 1.64294568 |
| 20 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.62285685 |
| 21 | Allograft rejection_Homo sapiens_hsa05330 | 1.60635342 |
| 22 | Homologous recombination_Homo sapiens_hsa03440 | 1.59105240 |
| 23 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.57361549 |
| 24 | Other glycan degradation_Homo sapiens_hsa00511 | 1.52910238 |
| 25 | Taste transduction_Homo sapiens_hsa04742 | 1.50903069 |
| 26 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.49471533 |
| 27 | GABAergic synapse_Homo sapiens_hsa04727 | 1.48275984 |
| 28 | Circadian entrainment_Homo sapiens_hsa04713 | 1.47659335 |
| 29 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.47511109 |
| 30 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.47416352 |
| 31 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.44732331 |
| 32 | Phototransduction_Homo sapiens_hsa04744 | 1.41673528 |
| 33 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.33295573 |
| 34 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.32513506 |
| 35 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.28356184 |
| 36 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.22432154 |
| 37 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.21299359 |
| 38 | Asthma_Homo sapiens_hsa05310 | 1.19954785 |
| 39 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.17575344 |
| 40 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.15807135 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.14629984 |
| 42 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.14119242 |
| 43 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.13355924 |
| 44 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.11666954 |
| 45 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.10988672 |
| 46 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.09761392 |
| 47 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.08255222 |
| 48 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.08117776 |
| 49 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.06634511 |
| 50 | RNA polymerase_Homo sapiens_hsa03020 | 1.03449304 |
| 51 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.03349372 |
| 52 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.03071919 |
| 53 | Insulin secretion_Homo sapiens_hsa04911 | 1.02973457 |
| 54 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.02635160 |
| 55 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.00708193 |
| 56 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.99771571 |
| 57 | Leishmaniasis_Homo sapiens_hsa05140 | 0.98740908 |
| 58 | Salivary secretion_Homo sapiens_hsa04970 | 0.98574192 |
| 59 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.98250756 |
| 60 | Long-term depression_Homo sapiens_hsa04730 | 0.97220897 |
| 61 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.97020903 |
| 62 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.95931628 |
| 63 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.95500195 |
| 64 | Purine metabolism_Homo sapiens_hsa00230 | 0.94597639 |
| 65 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.94449777 |
| 66 | ABC transporters_Homo sapiens_hsa02010 | 0.94058388 |
| 67 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.93887455 |
| 68 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.92436139 |
| 69 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.91512918 |
| 70 | Long-term potentiation_Homo sapiens_hsa04720 | 0.91353882 |
| 71 | Measles_Homo sapiens_hsa05162 | 0.90102940 |
| 72 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.89621789 |
| 73 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.89511696 |
| 74 | Basal transcription factors_Homo sapiens_hsa03022 | 0.87803740 |
| 75 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.87773418 |
| 76 | Peroxisome_Homo sapiens_hsa04146 | 0.86284138 |
| 77 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.85629586 |
| 78 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.84415268 |
| 79 | Renin secretion_Homo sapiens_hsa04924 | 0.83613506 |
| 80 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.83085848 |
| 81 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.82633989 |
| 82 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.81130316 |
| 83 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.81025611 |
| 84 | Thyroid cancer_Homo sapiens_hsa05216 | 0.79653345 |
| 85 | Base excision repair_Homo sapiens_hsa03410 | 0.78716765 |
| 86 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.77169675 |
| 87 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.76672102 |
| 88 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.76548693 |
| 89 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.75356357 |
| 90 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.75327296 |
| 91 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.75124865 |
| 92 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.74296340 |
| 93 | Pertussis_Homo sapiens_hsa05133 | 0.73752586 |
| 94 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.72563079 |
| 95 | Mismatch repair_Homo sapiens_hsa03430 | 0.70824985 |
| 96 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.70622472 |
| 97 | Cocaine addiction_Homo sapiens_hsa05030 | 0.68867875 |
| 98 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.68832203 |
| 99 | Alzheimers disease_Homo sapiens_hsa05010 | 0.68750588 |
| 100 | Parkinsons disease_Homo sapiens_hsa05012 | 0.68592864 |
| 101 | Circadian rhythm_Homo sapiens_hsa04710 | 0.65617452 |
| 102 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.65286526 |
| 103 | Tuberculosis_Homo sapiens_hsa05152 | 0.63986316 |
| 104 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.63720987 |
| 105 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.63156338 |
| 106 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.62490713 |
| 107 | Huntingtons disease_Homo sapiens_hsa05016 | 0.62200294 |
| 108 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.61562010 |
| 109 | Mineral absorption_Homo sapiens_hsa04978 | 0.60887135 |
| 110 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.60805454 |
| 111 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.59619968 |
| 112 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.59250224 |
| 113 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.58964607 |
| 114 | Malaria_Homo sapiens_hsa05144 | 0.58948619 |
| 115 | Axon guidance_Homo sapiens_hsa04360 | 0.57870867 |
| 116 | RNA degradation_Homo sapiens_hsa03018 | 0.57385954 |
| 117 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.57320179 |
| 118 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.57212571 |
| 119 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.56583460 |
| 120 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.56424052 |
| 121 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.56413563 |
| 122 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.55853821 |
| 123 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.54908910 |
| 124 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.54357740 |
| 125 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.54298565 |
| 126 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.53954278 |
| 127 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.53520450 |
| 128 | Salmonella infection_Homo sapiens_hsa05132 | 0.53183123 |
| 129 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.52755935 |
| 130 | Bile secretion_Homo sapiens_hsa04976 | 0.50489544 |
| 131 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.50268305 |
| 132 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.49727573 |
| 133 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.48528521 |
| 134 | Retinol metabolism_Homo sapiens_hsa00830 | 0.47927245 |
| 135 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.47237554 |
| 136 | Proteasome_Homo sapiens_hsa03050 | 0.45861616 |
| 137 | Phagosome_Homo sapiens_hsa04145 | 0.45804272 |
| 138 | Influenza A_Homo sapiens_hsa05164 | 0.45151753 |
| 139 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.44598152 |
| 140 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.44482469 |
| 141 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.41944909 |
| 142 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.41882471 |
| 143 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.41609046 |
| 144 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41252482 |
| 145 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.39978187 |
| 146 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.39355889 |
| 147 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.38649734 |
| 148 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.38030467 |
| 149 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.37181966 |

